Stock 6797 TAIWAN ADVANCED NANOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Taiwan Advanced Nanotech Inc.

Equities

6797

TW0006797004

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
26.9 TWD -2.54% Intraday chart for Taiwan Advanced Nanotech Inc. -4.10% -31.03%
2023 Taiwan Advanced Nanotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 Taiwan Advanced Nanotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 5,351 2,861 1,766
Enterprise Value (EV) 1 4,890 2,397 1,070
P/E ratio 8.33 x 4.82 x 5.56 x
Yield 5.53% 4.86% 5.11%
Capitalization / Revenue 3.11 x 1.48 x 1.33 x
EV / Revenue 2.84 x 1.24 x 0.81 x
EV / EBITDA 5.89 x 2.85 x 2.63 x
EV / FCF 10,624,819 x 7,440,769 x 4,782,863 x
FCF Yield 0% 0% 0%
Price to Book 5.64 x 2.24 x 1.21 x
Nbr of stocks (in thousands) 30,246 30,120 30,093
Reference price 2 176.9 95.00 58.70
Announcement Date 4/19/21 3/31/22 3/17/23
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 61.62 101.9 114 1,719 1,928 1,327
EBITDA 1 -6.01 -19.28 -35.47 830.5 840.9 406.5
EBIT 1 -14.12 -28.56 -45.56 797.7 800.8 344
Operating Margin -22.91% -28.03% -39.98% 46.4% 41.53% 25.93%
Earnings before Tax (EBT) 1 -16.14 -27.1 -44.77 773.1 791.3 460.7
Net income 1 -13.56 -20.94 -36.6 618.2 626 326
Net margin -22% -20.56% -32.12% 35.96% 32.46% 24.58%
EPS 2 -0.7832 -0.8951 -1.427 21.24 19.72 10.55
Free Cash Flow - -1.08 -61.21 460.2 322.1 223.7
FCF margin - -1.06% -53.71% 26.77% 16.7% 16.86%
FCF Conversion (EBITDA) - - - 55.41% 38.31% 55.02%
FCF Conversion (Net income) - - - 74.44% 51.45% 68.61%
Dividend per Share - - - 9.790 4.615 3.000
Announcement Date 8/18/20 8/18/20 8/18/20 4/19/21 3/31/22 3/17/23
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 31.7 105 5.27 462 465 697
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -1.08 -61.2 460 322 224
ROE (net income / shareholders' equity) - -13.9% -22.1% 113% 56.3% 25.6%
ROA (Net income/ Total Assets) - -9.64% -12.5% 47.1% 24.5% 9.49%
Assets 1 - 217.3 292.7 1,313 2,553 3,434
Book Value Per Share 2 6.770 7.160 5.740 31.30 42.30 48.70
Cash Flow per Share 2 2.660 4.040 2.830 22.00 12.30 23.40
Capex 1 7.82 2.62 11.6 127 175 45.3
Capex / Sales 12.69% 2.57% 10.22% 7.39% 9.1% 3.41%
Announcement Date 8/18/20 8/18/20 8/18/20 4/19/21 3/31/22 3/17/23
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
TAIWAN ADVANCED NANOTECH INC. Stock Taiwan Advanced Nanotech Inc.
-31.03% 25.27M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 6797 Stock
  4. Financials Taiwan Advanced Nanotech Inc.